221 related articles for article (PubMed ID: 26825353)
21. [The role of lens epithelium in cataract formation in diabetic rats].
Fan W; Yan M; Hu Y; Li G
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):185-8. PubMed ID: 10684012
[TBL] [Abstract][Full Text] [Related]
22. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
J Pharmacol Sci; 2008 Jan; 106(1):144-51. PubMed ID: 18187926
[TBL] [Abstract][Full Text] [Related]
23. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
Ahmad SS; Tsou KC; Ahmad SI; Rahman MA
Ophthalmic Res; 1985; 17(1):12-20. PubMed ID: 2984623
[TBL] [Abstract][Full Text] [Related]
24. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
Beyer-Mears A; Diecke FP; Mistry K; Ellison C; Cruz E
Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
[TBL] [Abstract][Full Text] [Related]
26. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
Kanth VR; Lavanya K; Srinivas J; Raju TN
Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
[TBL] [Abstract][Full Text] [Related]
27. Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies.
Hegde KR; Henein MG; Varma SD
Diabetes Obes Metab; 2003 Mar; 5(2):113-9. PubMed ID: 12630936
[TBL] [Abstract][Full Text] [Related]
28. Does oxidative stress play any role in diabetic cataract formation? ----Re-evaluation using a thioltransferase gene knockout mouse model.
Zhang J; Yan H; Lou MF
Exp Eye Res; 2017 Aug; 161():36-42. PubMed ID: 28579033
[TBL] [Abstract][Full Text] [Related]
29. Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity?
Kilic F; Bhardwaj R; Caulfeild J; Trevithick JR
Exp Eye Res; 1999 Sep; 69(3):291-300. PubMed ID: 10471337
[TBL] [Abstract][Full Text] [Related]
30. Absorbance and Light Scattering of Lenses Organ Cultured with Glucose.
Alghamdi AHS; Mohamed H; Sledge SM; Borchman D
Curr Eye Res; 2018 Oct; 43(10):1233-1238. PubMed ID: 29874948
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
32. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
[TBL] [Abstract][Full Text] [Related]
33. Aldose reductase expression as a risk factor for cataract.
Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
[TBL] [Abstract][Full Text] [Related]
34. The unfolded protein response in lens epithelial cells from galactosemic rat lenses.
Mulhern ML; Madson CJ; Danford A; Ikesugi K; Kador PF; Shinohara T
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3951-9. PubMed ID: 16936110
[TBL] [Abstract][Full Text] [Related]
35. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
[TBL] [Abstract][Full Text] [Related]
36. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
Suresha BS; Sattur AP; Srinivasan K
Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
[TBL] [Abstract][Full Text] [Related]
37. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
[TBL] [Abstract][Full Text] [Related]
38. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
40. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats.
Perry RE; Swamy MS; Abraham EC
Exp Eye Res; 1987 Feb; 44(2):269-82. PubMed ID: 3582512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
